[Generalized anxiety disorder (GAD)--diagnosis and therapy].

Med Monatsschr Pharm

Klinik für Psychiatrie und Psychotherapie CKQ, Zentrum für integrative Diagnostik und Therapie von Angsterkrankungen (ZIDTA), Akademisches Lehrkrankenhaus der MHH, Quakenbrück.

Published: November 2007

The GAD is an important psychiatric disorder with high comorbidity and often chronic course. The differentiation against depression is not easy. In this review evidence based standards of therapy are discussed. The complex etiology and pathogenesis give a rationale for an integrative therapeutic approach, but this does not necessarily mean a combination of pharmacotherapy and psychotherapy for every patient. The pharmacotherapy with SSRI, SNRI, opipramol, buspirone and pregabalin allows an effective treatment. The empirical validated behaviour therapy is alternatively possible. Both approaches include a respectable number of therapy non-responders.

Download full-text PDF

Source

Publication Analysis

Top Keywords

[generalized anxiety
4
anxiety disorder
4
disorder gad--diagnosis
4
gad--diagnosis therapy]
4
therapy] gad
4
gad psychiatric
4
psychiatric disorder
4
disorder high
4
high comorbidity
4
comorbidity chronic
4

Similar Publications

Importance: Mental health issues among young people are increasingly concerning. Conventional psychological interventions face challenges, including limited staffing, time commitment, and low completion rates.

Objective: To evaluate the effect of a low-intensity online intervention on young people in Hong Kong experiencing moderate or greater mental distress.

View Article and Find Full Text PDF

Background: Married or long-term partnered patients with chronic diseases generally have better outcomes than unmarried patients, likely due to the potential for multifaceted support. However, the impact of marital status on multiple sclerosis (MS) radiographic disease burden is currently unknown.

Objective: To compare total white matter hyperintensity lesion volumes, periventricular lesion volumes, and whole brain and grey matter volumes in married and unmarried people with MS (PwMS).

View Article and Find Full Text PDF

Late-onset Systemic Lupus Erythematosus.

Rheumatol Int

January 2025

Department of Rheumatology, Immunology and Internal Medicine, University Hospital in Kraków, Kraków, Poland.

Systemic lupus erythematosus (SLE) is a multisystem autoimmune rheumatic disease (ARD) that results from the dysregulation of multiple innate and adaptive immune pathways. Late-onset SLE (Lo-SLE) is the term used when the disease is first diagnosed after 50-65 years, though the standard age cut-off remains undefined. Defining "late-onset" as lupus with onset after 50 years is more biologically plausible as this roughly corresponds to the age of menopause.

View Article and Find Full Text PDF

Gestational diabetes and mental health: longitudinal analysis of data from the GEMS randomized trial.

Arch Womens Ment Health

January 2025

Liggins Institute, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland, 1023, New Zealand.

Purpose: There is limited high-quality evidence about perinatal mental health among women with gestational diabetes. We aimed to assess the risks and longitudinal changes in anxiety, depression, and health-related quality of life comparing women with gestational diabetes and those without among a contemporary cohort of pregnant women.

Methods: Prospective cohort study of participants in the GEMS Trial.

View Article and Find Full Text PDF

Introduction: Despite the emergence of drugs to treat irritable bowel syndrome (IBS), improving abdominal pain can still be challenging. αδ ligands, such as gabapentin and pregabalin, are sometimes used off-label to tackle this problem. However, evidence for efficacy is limited, and no large-scale studies have been published.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!